222 related articles for article (PubMed ID: 10693152)
1. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
Ströhle A; Holsboer F; Rupprecht R
Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
[TBL] [Abstract][Full Text] [Related]
2. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
[TBL] [Abstract][Full Text] [Related]
3. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
Demiralay C; Agorastos A; Yassouridis A; Jahn H; Wiedemann K; Kellner M
Psychoneuroendocrinology; 2017 Feb; 76():14-18. PubMed ID: 27871026
[TBL] [Abstract][Full Text] [Related]
4. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K
World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
[TBL] [Abstract][Full Text] [Related]
5. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
[TBL] [Abstract][Full Text] [Related]
6. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
Eser D; di Michele F; Zwanzger P; Pasini A; Baghai TC; Schüle C; Rupprecht R; Romeo E
Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
[TBL] [Abstract][Full Text] [Related]
7. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
Wiedemann K; Jahn H; Yassouridis A; Kellner M
Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
[TBL] [Abstract][Full Text] [Related]
8. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
Zwanzger P; Eser D; Völkel N; Baghai TC; Möller HJ; Rupprecht R; Padberg F
Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
Zwanzger P; Baghai TC; Schuele C; Ströhle A; Padberg F; Kathmann N; Schwarz M; Möller HJ; Rupprecht R
Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
[TBL] [Abstract][Full Text] [Related]
12. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
Eser D; Leicht G; Baghai T; Pogarell O; Schüle C; Karch S; Nothdurfter C; Rupprecht R; Mulert C
J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
[TBL] [Abstract][Full Text] [Related]
13. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
Kellner M; Yassouridis A; Jahn H; Wiedemann K
Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081
[TBL] [Abstract][Full Text] [Related]
14. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
[TBL] [Abstract][Full Text] [Related]
15. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
Abelson JL; Khan S; Liberzon I; Young EA
Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
[TBL] [Abstract][Full Text] [Related]
16. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
[TBL] [Abstract][Full Text] [Related]
17. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
[TBL] [Abstract][Full Text] [Related]
18. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
Koszycki D; Zacharko RM; Le Mellédo JM; Bradwejn J
Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic.
Ruland T; Domschke K; Schütte V; Zavorotnyy M; Kugel H; Notzon S; Vennewald N; Ohrmann P; Arolt V; Pfleiderer B; Zwanzger P
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1677-82. PubMed ID: 26235955
[TBL] [Abstract][Full Text] [Related]
20. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.
Zwanzger P; Zavorotnyy M; Gencheva E; Diemer J; Kugel H; Heindel W; Ruland T; Ohrmann P; Arolt V; Domschke K; Pfleiderer B
Neuropsychopharmacology; 2013 Aug; 38(9):1648-54. PubMed ID: 23463151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
